Pay in 4 interest-free payments of $6.22 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
Patients were followed up from the index date until death, loss to follow-up, development of a clinical outcome of interest, or the end of 2016, whichever came first, as the intention-to-treated (ITT) analysis scenario
PMID: 39491755
Loss of muscle mass: Evidence suggests most individuals experience lean mass loss with these therapies
The medication's 7-day half-life creates enough flexibility to tolerate minor timing variations without increased side effects or reduced efficacy
US$ 22.28
US$ 26.00
US$ 29.35
US$ 26.46
US$ 23.43
US$ 29.92
US$ 26.77
US$ 24.24
US$ 24.51
US$ 25.61
